Connect your AI

Edwards Lifesciences EW Total Equity

Total Equity at other companies

Cabot CorporationCBT

$1.57B+9.9%

UnifirstUNF

$2.18B+1.9%

Main Street CapitalMAIN

$3.09B+8.9%

BeldenBDC

$1.28B+4.9%

Sharplink, Inc. SBET

$1.74B+83,286%

Middlesex Water CompanyMSEX

$501.05M+11.6%

Other financials

Income statement

Revenue$1.6B+16.7%

Gross profit$1.3B+15.7%

Operating income$477.6M+21.0%

Net income$380.7M+6.3%

EPS (diluted)$0.66+8.2%

Balance sheet

Cash & equivalents$2.4B-22.3%

Total debt$702.9M+0.5%

Total assets$13.3B+2.3%

Cash flow

Operating cash flow$43.8M-84.4%

CapEx$64.9M+15.9%

Free cash flow-$21.1M-109%

Valuation

Market cap$51.66B+19.3%

Enterprise value$49.92B+22.2%

P/E47.1×+36.8×

P/S8.2×+0.4×

Profitability

Gross margin77.9%-1.6pp

Operating margin21.4%-4.4pp

Net margin17.4%-58.3pp

FCF margin17.3%—

Returns & leverage

Return on equity10.7%-37.8pp

Debt / equity0.1×0.0×

Current ratio4.4×0.0×

Where this comes from

Reported directly by Edwards Lifesciences in its filing.

Tagged under the XBRL concept us-gaap:StockholdersEquity.

The official record: Edwards Lifesciences’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Edwards Lifesciences's total equity.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Harbor at dusk

Questions, answered.

What is Edwards Lifesciences's total equity?: Edwards Lifesciences (EW) reported total equity of $10.33B in Q1 2026.
How has Edwards Lifesciences's total equity changed year-over-year?: Edwards Lifesciences's total equity increased by 2.0% year-over-year, from $10.13B to $10.33B.
What is the long-term trend for Edwards Lifesciences's total equity?: Over 5 years (2020 to 2025), Edwards Lifesciences's total equity has grown at a 17.7% compound annual growth rate (CAGR), from $4.57B to $10.34B.
What does total equity mean?: Net assets attributable to shareholders — total assets minus total liabilities. Represents the book value of shareholders' ownership claim.